Solid Biosciences (SLDB) Capital Leases (2018 - 2024)
Solid Biosciences (SLDB) reported Capital Leases of $307000.0 for Q3 2024, down 77.46% on a YoY basis from $1.4 million in Q4 2023, and down 67.79% sequentially from $953000.0 in Q2 2024.
Solid Biosciences (SLDB) Capital Leases (2018 - 2024) Analysis & Trends
Solid Biosciences (SLDB) has 7 years of Capital Leases data on file, last reported at $307000.0 in Q3 2024.
- For the quarter ending Q3 2024, Capital Leases fell 77.46% year-over-year to $307000.0; the trailing twelve-month figure through Sep 2024 stood at $307000.0 (down 77.46% YoY), and the FY2023 full-year result was $1.2 million, down 27.54% from the prior year.
- Capital Leases declined to $307000.0 in Q3 2024, from $953000.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $1.7 million in Q4 2022 to a low of $231000.0 in Q1 2022.
- A 5-year average of $818470.6 and a median of $632000.0 in 2020 frame the typical range for Capital Leases.
- Across the five-year window, Capital Leases soared 590.91% in 2023 and plunged 77.46% in 2024, its largest moves.
- Tracing SLDB's Capital Leases over 5 years: stood at $525000.0 in 2020, then tumbled by 44.19% to $293000.0 in 2021, then soared by 481.23% to $1.7 million in 2022, then fell by 27.54% to $1.2 million in 2023, then tumbled by 75.12% to $307000.0 in 2024.
- Business Quant data shows SLDB's Capital Leases at $307000.0 in Q3 2024, $953000.0 in Q2 2024, and $1.1 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Solid Biosciences | 529.40 Mn | 529.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 307,000.00 |
| Jun 30, 2024 | 953,000.00 |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 1.48 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 1.70 Mn |
| Mar 31, 2022 | 231,000.00 |
| Dec 31, 2021 | 293,000.00 |
| Sep 30, 2021 | 353,000.00 |
| Jun 30, 2021 | 412,000.00 |
| Mar 31, 2021 | 469,000.00 |
| Dec 31, 2020 | 525,000.00 |
| Sep 30, 2020 | 579,000.00 |
| Jun 30, 2020 | 632,000.00 |
| Mar 31, 2020 | 683,000.00 |
| Dec 31, 2019 | 733,000.00 |
| Sep 30, 2019 | 782,000.00 |
| Jun 30, 2019 | 829,000.00 |